EASL 2025 Abstract Highlights
Abstract
Translate Article 
The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver (EASL) Congress 2025.Topics ranged from alanine transaminase testing as a screening tool for paediatric metabolic dysfunction-associated steatotic liver disease to the risks of moderate alcohol use in liver disease, and novel siRNA therapies for hepatitis B.